Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06686940

Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden

The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Atrial fibrillation patients diagnosed by electrocardiogram
  • Willing to use long-range electrocardiogram monitoring equipment

Exclusion criteria

1.Patients who are allergic to electronic devices or unable to wear watches

Treatment and study plan

Intervention Group

Device

The monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.

Primary outcomes

  1. Primary outcome

    Time frame: December 30, 2024 to Decemberr 30, 2034

    all-cause death, cardiovascular death, myocardial infarction, heart failure, stroke, peripheral vascular disease, recurrence of atrial fibrillation diagnosed by electrocardiogram, palpitations symptoms

Study contacts

Contact information is provided by the study sponsor or research team.

Song Zuo, M.D

CONTACT

[email protected]

1880142775

Sponsors and collaborators

Lead sponsor

Beijing Anzhen Hospital

Other

Registry information

Acronym: Polaris-AF

Important dates

Study start
2024
Primary completion
2034
Study completion
2034
First posted
Nov 13, 2024
Registry last updated
Nov 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.